This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.35% per year. These returns cover a period from January 1, 1988 through December 2, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Analyst Blog: Archive
Landstar Continues to Grapple With Weakness in Freight Market
by Zacks Equity Research
Weakness in overall volumes due to headwinds like weak freight demand, supply-chain woes and slower network velocity are hurting LSTR's top line.
CHRWNegative Net Change WABPositive Net Change LSTRNegative Net Change
transportation
BXP Witnesses Strong Leasing Momentum, Gets Renewal From Ropes & Gray
by Zacks Equity Research
BXP secures a lease renewal with Ropes & Gray at the Prudential Tower in Boston, MA, emblematic of continued client confidence in the office REIT.
HIWPositive Net Change BXPPositive Net Change CCINegative Net Change
finance reit
4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025
by Sridatri Sarkar
Investing in large-cap MedTech stocks like MCK, PEN, CAH and PEN can be profitable for investors in 2025.
CAHPositive Net Change MCKPositive Net Change RMDPositive Net Change PENNegative Net Change
medical
MRK's Pivotal Study on Two-Drug, Once-Daily HIV Pill Meets Goals
by Zacks Equity Research
Merck posts positive data from two phase III studies evaluating a two-drug, single-tablet regimen of doravirine/islatravir in adults with HIV-1 infection.
MRKNegative Net Change GILDPositive Net Change SPRONegative Net Change CSTLPositive Net Change
pharmaceuticals
Four Corners Continues Its Acquisition Spree With Multiple Properties
by Zacks Equity Research
FCPT indulges in numerous strategic acquisitions to materialize its portfolio expansion efforts.
HIWPositive Net Change CCINegative Net Change FCPTPositive Net Change
finance reit
Afya to Expand Medical Education Reach With FUNIC Acquisition
by Zacks Equity Research
AFYA has announced a share purchase agreement to acquire 100% of FUNIC.
STRANegative Net Change UTINegative Net Change LRNNegative Net Change AFYAPositive Net Change
consumer-discretionary
Uncover These 5 Undervalued Tech Giants Before They Skyrocket in 2025
by Anirudha Bhagat
Discover five undervalued tech giants poised to soar in 2025, driven by AI, cloud and 5G growth opportunities.
QCOMPositive Net Change NVDAPositive Net Change TWLOPositive Net Change DBXPositive Net Change ZMPositive Net Change
artificial-intelligence business-services cloud-computing computers internet internet-content saas semiconductor tech-stocks
SNN Stock May Gain on CORIOGRAPH Platform's FDA Clearance for THA
by Zacks Equity Research
Smith & Nephew announces FDA clearance for its CORIOGRAPH platform for total hip arthroplasty.
ABTPositive Net Change SNNNegative Net Change MASINegative Net Change AXGNPositive Net Change
medical medical-devices
Cintas' Q2 Earnings & Revenues Surpass Estimates, EPS View Up
by Zacks Equity Research
CTAS' second-quarter fiscal 2025 organic revenues increase 7.1% year over year on solid segmental sales.
RBCNegative Net Change CTASPositive Net Change AITNegative Net Change GHMPositive Net Change
business-services
BlackBerry's Q3 Earnings Top Estimates, Revenues Down Y/Y, Stock Rises
by Zacks Equity Research
BB's fiscal third-quarter earnings surpass guidance. Revenues decline year over year due to tough comparisons.
CIENPositive Net Change NTAPPositive Net Change PSTGPositive Net Change BBPositive Net Change
tech-stocks
Boeing Wins Order for up to 200 737 Max Jets From Pegasus Airlines
by Zacks Equity Research
BA secures a contract with Pegasus Airlines for 100 737-10 jets, with options for additional 100 jets.
BAPositive Net Change GDPositive Net Change TXTPositive Net Change EADSYNegative Net Change
aerospace
ITRI, XEL Team Up to Power DER Management: Will Itron Stock Benefit?
by Zacks Equity Research
Itron and Xcel Energy collaborate to optimize distributed energy resources, aiming to innovate the future of the energy landscape.
XELPositive Net Change ITRIPositive Net Change PLXSNegative Net Change IDCCPositive Net Change
energy tech-stocks utilities
Buy These 5 3D Printing Stocks to Strengthen Your Portfolio for 2025
by Nalak Das
Five 3D printing stocks have strong revenues and earnings growth potential for 2025 and solid short-term upside. These are: ADSK, NVDA, GE, LHX, CSR.
GEPositive Net Change NVDAPositive Net Change ADSKPositive Net Change CRSPositive Net Change LHXPositive Net Change
aerospace basic-materials computers semiconductor
Can Sony's Gaming Segment Fuel its Growth Momentum in 2025?
by Shreya Majumder
SONY is set to thrive in 2025, with momentum in gaming, music, entertainment and semiconductors, and its dominance in the global audio-video industry.
DLBNegative Net Change SONOPositive Net Change SONYPositive Net Change
tech-stocks
Buy 5 Value Stocks Amid Strong Upside Potential in the Short Term
by Nalak Das
Five value stocks have strong revenues and earnings potential in 2025. These are: FAF, MCK, LDOS, SKYW, GAP.
MCKPositive Net Change FAFPositive Net Change GAPPositive Net Change SKYWNegative Net Change LDOSPositive Net Change
aerospace airlines insurance medical retail
3 Key Reasons Why Disney is a Stock to Buy Ahead of 2025
by Vasundhara Sawalka
DIS' streaming profitability, IP expansion and parks growth signal strong potential. With robust 2025 forecasts and strategic initiatives, now is the time to buy.
AMZNPositive Net Change AAPLPositive Net Change NFLXPositive Net Change DISPositive Net Change
consumer-discretionary internet-content
Frontdoor Completes Acquisition of 2-10 Home Buyers Warranty
by Zacks Equity Research
FTDR strengthens its portfolio with the acquisition of 2-10 HBW and secures a $1.47 billion credit facility to support growth and strategic initiatives.
FIXPositive Net Change STRLPositive Net Change MTZPositive Net Change FTDRPositive Net Change
construction
Coty Stock Slumps 24% in 3 Months: What's Next for Investors?
by Zacks Equity Research
COTY is facing challenges like higher costs, struggles in the Chinese Mainland and currency woes, raising concerns about its future growth.
ANFPositive Net Change DECKPositive Net Change URBNPositive Net Change COTYPositive Net Change
consumer-staples
Here's What Makes JD.com Stock Worth a Watch Ahead of 2025
by Vasundhara Sawalka
JD shows promise for 2025 with a Chilean partnership, strong Singles Day sales and expanding global reach. Rising margins and a new buyback plan signal growth potential.
JDNegative Net Change BABANegative Net Change PDDNegative Net Change
e-commerce internet-content
At 38.8X P/E, Is e.l.f. Beauty Stock Still Worth the Splurge?
by Vrishali Bagree
e.l.f. Beauty faces valuation concerns and rising costs but showcases potential through innovation, retail expansion and strong digital performance.
TGTPositive Net Change DGPositive Net Change ELNegative Net Change ELFNegative Net Change
consumer-staples
Here's Why You Should Add ONE Gas Stock to Your Portfolio Now
by Zacks Equity Research
OGS makes a strong case for investment, given its growth prospects, capability to increase shareholders' value and debt management.
NIPositive Net Change ATOPositive Net Change NJRPositive Net Change OGSPositive Net Change
utilities
BP, Iraq Advance Redevelopment of Kirkuk Oil Fields
by Zacks Equity Research
BP and Iraq agree on technical terms to redevelop the Kirkuk oilfields, aiming for a deal by early 2025. The project holds the potential for enhanced oil output and renewable energy integration.
BPPositive Net Change FTIPositive Net Change FCELPositive Net Change NINEPositive Net Change
energy oil-energy
How to Play JPMorgan Stock as Fed Hints Fewer Rate Cuts for 2025?
by Swayta Shah
Fewer rate cuts in 2025 will somewhat support JPM's NII. Is the stock worth considering now or should you wait? Read on to find out.
BACPositive Net Change JPMPositive Net Change CPositive Net Change
banking finance
Ionis Gets FDA Approval for Rare Disease Drug Tryngolza
by Zacks Equity Research
The FDA's nod to IONS' Tryngolza makes it the first approved treatment for FCS. It is also the company's first wholly-owned drug to receive marketing approval.
AZNPositive Net Change GSKPositive Net Change BIIBNegative Net Change IONSPositive Net Change
medical pharmaceuticals
Buy These 5 Stocks With Low Price-to-Sales Ratio for High Returns
by Rajani Lohia
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like JAKK, AGR, PCB, FIHL and GBX hold promise.
JAKKPositive Net Change GBXPositive Net Change AGRPositive Net Change PCBPositive Net Change FIHLPositive Net Change
consumer-discretionary finance insurance transportation utilities